AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioAtla, Inc. Director's Dealing 2023

Jul 3, 2023

34681_dirs_2023-07-03_6502f1f9-1d17-4e45-8590-b4d7a9f56c25.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2023-06-30

Reporting Person: Smith Scott Andrew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-30	Common Stock	F	1791	$3.00	Disposed	309744	Direct

Footnotes

F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.